The Dengue Testing Market report points out national and global business prospects and competitive conditions for dengue testing. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for dengue testing. The dengue testing market has been segmented by product type (elisa-based tests, rt-pcr based tests and dengue igg/igm rapid test, other tests), by end-user (hospitals, diagnostic centers, others). Historical background for the demand of dengue testing has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand dengue testing have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.
Market Segmentation:
By Product Type:
- ELISA-based Tests
- RT-PCR based Tests and Dengue IgG/IgM Rapid Test
- Other Tests
By End-User:
- Hospitals
- Diagnostic Centers
- Others
By Region:
North America Dengue Testing Market
- North America, by Country
- US
- Canada
- Mexico
- North America, by Product Type
- North America, by End-User
Europe Dengue Testing Market
- Europe, by Country
- Germany
- Russia
- UK
- France
- Italy
- Spain
- The Netherlands
- Rest of Europe
- Europe, by Product Type
- Europe, by End-User
Asia Pacific Dengue Testing Market
- Asia Pacific, by Country
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Rest of Asia Pacific
- Asia Pacific, by Product Type
- Asia Pacific, by End-User
Middle East & Africa Dengue Testing Market
- Middle East & Africa, by Country
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
- Middle East & Africa, by Product Type
- Middle East & Africa, by End-User
South America Dengue Testing Market
- South America, by Country
- Brazil
- Argentina
- Colombia
- Rest of South America
- South America, by Product Type
- South America, by End-User
Major Companies: Abbott Laboratories, NovaTec Immundiagnostica GmbH, Euroimmun AG (PerkinElmer), F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., and InBios International, Inc.
Years Covered in the Study:
Historic Year: 2017-2018
Base Year: 2019
Estimated Year: 2020
Forecast Year: 2028
Objectives of this report:
- To estimate market size for dengue testing market on regional and global basis.
- To identify major segments in dengue testing market and evaluate their market shares and demand.
- To provide a competitive scenario for the dengue testing market with major developments observed by key companies in the historic years.
- To evaluate key factors governing the dynamics of dengue testing market with their potential gravity during the forecast period.
Reasons to Buy This Report:
- Provides niche insights for decision about every possible segment helping in strategic decision making process.
- Market size estimation of the dengue testing market on a regional and global basis.
- A unique research design for market size estimation and forecast.
- Identification of major companies operating in the market with related developments
- Exhaustive scope to cover all the possible segments helping every stakeholder in the dengue testing
Customization:
This study is customized to meet your specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
- Product Specific Competitive Analysis
For more information, contact: sales@quincemarketinsights.com